Phase 3 Stage II-III Non-small Cell Lung Cancer Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 3

Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH)

Stage II-III Non-small Cell Lung Cancer

Shanghai Chest Hospital478 enrolled1 locationNCT06437977

Recruiting

Phase 3

Effect of Infusion Timing on Pathologic Response to Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer

Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC)

Hunan Province Tumor Hospital156 enrolled2 locationsNCT07251582